{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T09:26:54Z","timestamp":1793957214910,"version":"4.8.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.msard.2026.107946","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:38:36Z","timestamp":1790404716000},"page":"107946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Metabolic reprogramming in neuromyelitis optica spectrum disorder: From astrocyte dysfunction to immune-mediated neuroinflammation"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6460-6165","authenticated-orcid":false,"given":"Xinyue","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nannan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.msard.2026.107946_bib0001","doi-asserted-by":"crossref","first-page":"5574","DOI":"10.4049\/jimmunol.177.8.5574","article-title":"IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program","volume":"177","author":"Argaw","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.msard.2026.107946_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1166490","article-title":"Efficacy and safety of monoclonal antibody therapy in patients with neuromyelitis optica spectrum disorder: a systematic review and network meta-analysis","volume":"14","author":"Aungsumart","year":"2023","journal-title":"Front. Neurol."},{"issue":"9","key":"10.1016\/j.msard.2026.107946_bib0003","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a041355","article-title":"The astrocyte: metabolic hub of the brain","volume":"16","author":"Barros","year":"2024","journal-title":"Cold. Spring. Harb. Perspect. Biol."},{"issue":"10","key":"10.1016\/j.msard.2026.107946_bib0004","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1002\/acn3.52171","article-title":"B cell and aquaporin-4 antibody relationships with neuromyelitis optica spectrum disorder activity","volume":"11","author":"Bennett","year":"2024","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.msard.2026.107946_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1166085","article-title":"Profile and potential role of novel metabolite biomarkers, especially indoleacrylic acid, in pathogenesis of neuromyelitis optica spectrum disorders","volume":"14","author":"Bian","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.msard.2026.107946_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002084","article-title":"Metabolic alterations of the immune system in the pathogenesis of autoimmune diseases","volume":"21","author":"Blanco","year":"2023","journal-title":"PLoS. Biol."},{"issue":"3","key":"10.1016\/j.msard.2026.107946_bib0007","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.autrev.2018.01.001","article-title":"Diagnosis and management of neuromyelitis optica spectrum disorders - an update","volume":"17","author":"Bruscolini","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.msard.2026.107946_bib0008","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.2147\/NDT.S425759","article-title":"Peripheral blood Th1\/Th17 immune cell shift is associated with disease activity and severity of AQP4 antibody sero-positive Neuromyelitis Optica spectrum disorder","volume":"19","author":"Cao","year":"2023","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"1","key":"10.1016\/j.msard.2026.107946_bib0009","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12974-021-02249-1","article-title":"Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies","volume":"18","author":"Carnero Contentti","year":"2021","journal-title":"J. Neuroinflammation."},{"issue":"11","key":"10.1016\/j.msard.2026.107946_bib0010","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1007\/s12035-023-03475-9","article-title":"Aquaporin-4 deficiency is associated with cognitive impairment and alterations in astrocyte-neuron lactate shuttle","volume":"60","author":"Cha","year":"2023","journal-title":"Mol. Neurobiol."},{"issue":"10","key":"10.1016\/j.msard.2026.107946_bib0011","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202100637R","article-title":"Neuromyelitis optica (NMO)-IgG-driven organelle reorganization in human iPSC-derived astrocytes","volume":"35","author":"Cho","year":"2021","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.msard.2026.107946_bib0012","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1093\/brain\/awz106","article-title":"Early B cell tolerance defects in neuromyelitis optica favour anti-AQP4 autoantibody production","volume":"142","author":"Cotzomi","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.msard.2026.107946_bib0013","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3389\/fncel.2019.00142","article-title":"Role of glutamatergic excitotoxicity in Neuromyelitis Optica spectrum disorders","volume":"13","author":"da Silva","year":"2019","journal-title":"Front. Cell Neurosci."},{"issue":"7","key":"10.1016\/j.msard.2026.107946_bib0014","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4533","article-title":"Nontarget metabolomics profiling of neuromyelitis optica spectrum disorder","volume":"33","author":"Deng","year":"2019","journal-title":"Biomed. Chromatogr."},{"issue":"2","key":"10.1016\/j.msard.2026.107946_bib0015","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1017\/cjn.2021.508","article-title":"Complement inhibition in Myasthenia Gravis and Neuromyelitis Optica spectrum disorder","volume":"50","author":"Dodig","year":"2023","journal-title":"Can. J. Neurol. Sci."},{"issue":"1","key":"10.1016\/j.msard.2026.107946_bib0016","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1042\/EBC20220077","article-title":"Astrocyte strategies in the energy-efficient brain","volume":"67","author":"Fern\u00e1ndez-Gonz\u00e1lez","year":"2023","journal-title":"Essays Biochem."},{"issue":"3","key":"10.1016\/j.msard.2026.107946_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230691","article-title":"Changes in mitochondrial function in patients with neuromyelitis optica; correlations with motor and cognitive disabilities","volume":"15","author":"Foolad","year":"2020","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.msard.2026.107946_bib0018","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s40478-025-02019-7","article-title":"Complement inhibition rapidly blocks lesion extension and facilitates remyelination in neuromyelitis optica","volume":"13","author":"Given","year":"2025","journal-title":"Acta Neuropathol. Commun."},{"issue":"4","key":"10.1016\/j.msard.2026.107946_bib0019","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/brain\/awab394","article-title":"Spectrum of sublytic astrocytopathy in neuromyelitis optica","volume":"145","author":"Guo","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.msard.2026.107946_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2026.1721230","article-title":"Mitochondrial metabolic reprogramming, quality control, and intercellular transfer in regulating macrophage plasticity","volume":"17","author":"He","year":"2026","journal-title":"Front. Physiol."},{"issue":"21","key":"10.1016\/j.msard.2026.107946_bib0021","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1073\/pnas.1701960114","article-title":"Autoantibody-induced internalization of CNS AQP4 water channel and EAAT2 glutamate transporter requires astrocytic fc receptor","volume":"114","author":"Hinson","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.msard.2026.107946_bib0022","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1084\/jem.20081241","article-title":"Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2","volume":"205","author":"Hinson","year":"2008","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.msard.2026.107946_bib0023","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11064-024-04306-6","article-title":"Physiological and pathological role of mTOR signaling in astrocytes","volume":"50","author":"Hochmuth","year":"2025","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.msard.2026.107946_bib0024","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12974-021-02375-w","article-title":"Dysregulated B cell differentiation towards antibody-secreting cells in neuromyelitis optica spectrum disorder","volume":"19","author":"Hoshino","year":"2022","journal-title":"J. Neuroinflammation."},{"issue":"10","key":"10.1016\/j.msard.2026.107946_bib0025","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1007\/s11064-017-2296-7","article-title":"Rapamycin ameliorates experimental autoimmune encephalomyelitis by suppressing the mTOR-STAT3 pathway","volume":"42","author":"Hou","year":"2017","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.msard.2026.107946_bib0026","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41392-024-01954-6","article-title":"Metabolic regulation of the immune system in health and diseases: mechanisms and interventions","volume":"9","author":"Hu","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.msard.2026.107946_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1687755","article-title":"Metabolic reprogramming as a therapeutic target for modulating the Th17\/Treg balance in autoimmune diseases: a comprehensive review","volume":"16","author":"Hu","year":"2025","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.msard.2026.107946_bib0028","doi-asserted-by":"crossref","first-page":"C1062","DOI":"10.1152\/ajpcell.00478.2024","article-title":"Metabolic T-cell phenotypes: from bioenergetics to function","volume":"328","author":"Jantz-Naeem","year":"2025","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"7","key":"10.1016\/j.msard.2026.107946_bib0029","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1007\/s00415-023-11634-0","article-title":"Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the neuromyelitis optica study group (NEMOS). part i: diagnosis and differential diagnosis","volume":"270","author":"Jarius","year":"2023","journal-title":"J. Neurol."},{"issue":"11","key":"10.1016\/j.msard.2026.107946_bib0030","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1172\/JCI86504","article-title":"mTOR has distinct functions in generating versus sustaining humoral immunity","volume":"126","author":"Jones","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.msard.2026.107946_bib0031","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s40478-017-0495-8","article-title":"Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease","volume":"5","author":"Jurynczyk","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"issue":"3","key":"10.1016\/j.msard.2026.107946_bib0032","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41593-025-01875-9","article-title":"CLEC16A in astrocytes promotes mitophagy and limits pathology in a multiple sclerosis mouse model","volume":"28","author":"Kadowaki","year":"2025","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.1016\/j.msard.2026.107946_bib0033","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200533","article-title":"Progression independent of relapse activity in aquaporin-4-IgG-positive NMOSD: a decade-long cohort study","volume":"13","author":"Kang","year":"2026","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"7","key":"10.1016\/j.msard.2026.107946_bib0034","first-page":"4899","article-title":"Effect of alpha-lipoic acid on asymmetric dimethylarginine and disability in multiple sclerosis patients: a randomized clinical trial","volume":"9","author":"Khalili","year":"2017","journal-title":"Electron. Phys."},{"issue":"1","key":"10.1016\/j.msard.2026.107946_bib0035","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1113\/JP280572","article-title":"Regulation of glycolysis by the hypoxia-inducible factor (HIF): implications for cellular physiology","volume":"599","author":"Kierans","year":"2021","journal-title":"J. Physiol."},{"issue":"7","key":"10.1016\/j.msard.2026.107946_bib0036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181758","article-title":"Metabolomic profiling of CSF in multiple sclerosis and neuromyelitis optica spectrum disorder by nuclear magnetic resonance","volume":"12","author":"Kim","year":"2017","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.msard.2026.107946_bib0037","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00415-023-11910-z","article-title":"Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the neuromyelitis optica study group (NEMOS). part ii: attack therapy and long-term management","volume":"271","author":"K\u00fcmpfel","year":"2024","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2026.107946_bib0038","article-title":"B cell metabolism in autoimmune diseases: signaling pathways and interventions","volume":"14","author":"Li","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.msard.2026.107946_bib0039","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12974-018-1095-7","article-title":"Enhanced glycolysis contributes to the pathogenesis of experimental autoimmune neuritis","volume":"15","author":"Liu","year":"2018","journal-title":"J. Neuroinflammation."},{"issue":"2","key":"10.1016\/j.msard.2026.107946_bib0040","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/glia.24271","article-title":"Remyelination in neuromyelitis optica spectrum disorder is promoted by edaravone through mTORC1 signaling activation","volume":"71","author":"Luo","year":"2023","journal-title":"Glia"},{"issue":"3","key":"10.1016\/j.msard.2026.107946_bib0041","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41590-025-02102-0","article-title":"B cell immunometabolism in health and disease","volume":"26","author":"Martinis","year":"2025","journal-title":"Nat. Immunol."},{"issue":"8","key":"10.1016\/j.msard.2026.107946_bib0042","first-page":"744","article-title":"Biologic therapy and brain atrophy in neuromyelitis optica: a Japanese-German longitudinal MRI study","volume":"97","author":"Masuda","year":"2026","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"9","key":"10.1016\/j.msard.2026.107946_bib0043","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.3390\/ijms27093871","article-title":"Mitochondria as an integrative hub of cellular homeostasis and stress response","volume":"27","author":"Mihaylova","year":"2026","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.msard.2026.107946_bib0044","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1212\/WNL.0000000000011153","article-title":"Worldwide incidence and prevalence of Neuromyelitis Optica: a systematic review","volume":"96","author":"Papp","year":"2021","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.msard.2026.107946_bib0045","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3390\/ijms24098059","article-title":"Appraising the role of astrocytes as suppliers of neuronal glutathione precursors","volume":"24","author":"P\u00e9rez-Sala","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.msard.2026.107946_bib0046","doi-asserted-by":"crossref","DOI":"10.1093\/oxfimm\/iqad005","article-title":"A cellular overview of immunometabolism in systemic lupus erythematosus","volume":"4","author":"Psarras","year":"2023","journal-title":"Oxf. Open. Immunol."},{"issue":"1","key":"10.1016\/j.msard.2026.107946_bib0047","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40035-026-00562-4","article-title":"Metabolic crosstalk in the ageing brain: astrocyte-neuron coupling as a target for homeostatic restoration and therapy","volume":"15","author":"Qian","year":"2026","journal-title":"Transl. Neurodegener."},{"issue":"3","key":"10.1016\/j.msard.2026.107946_bib0048","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/BOR.0000000000000791","article-title":"Recent advances in the treatment of neuromyelitis optica spectrum disorders","volume":"33","author":"Romeo","year":"2021","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.msard.2026.107946_bib0049","doi-asserted-by":"crossref","DOI":"10.1177\/17562864251345792","article-title":"Investigation of the association of serum GFAP and NfL with brain and upper cervical MRI volumes in AQP4-IgG-positive NMOSD and MOGAD","volume":"18","author":"Schindler","year":"2025","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"10.1016\/j.msard.2026.107946_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2023.107850","article-title":"Research progress on pathogenesis and clinical treatment of neuromyelitis optica spectrum disorders (NMOSDs)","volume":"231","author":"Shen","year":"2023","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"7","key":"10.1016\/j.msard.2026.107946_bib0051","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1084\/jem.20110278","article-title":"HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and treg cells","volume":"208","author":"Shi","year":"2011","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.msard.2026.107946_bib0052","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-70203-x","article-title":"Mitochondrial DNA enhance innate immune responses in neuromyelitis optica by monocyte recruitment and activation","volume":"10","author":"Shimizu","year":"2020","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.msard.2026.107946_bib0053","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41580-022-00547-x","article-title":"New insights into activation and function of the AMPK","volume":"24","author":"Steinberg","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.msard.2026.107946_bib0054","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jneuroim.2016.01.014","article-title":"Metformin ameliorates the development of experimental autoimmune encephalomyelitis by regulating T helper 17 and regulatory T cells in mice","volume":"292","author":"Sun","year":"2016","journal-title":"J. Neuroimmunol."},{"issue":"5","key":"10.1016\/j.msard.2026.107946_bib0055","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3390\/cells11050813","article-title":"Metabolic contribution and cerebral blood flow regulation by astrocytes in the neurovascular unit","volume":"11","author":"Takahashi","year":"2022","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.msard.2026.107946_bib0056","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3390\/nu13051697","article-title":"Coenzyme Q(10): clinical applications beyond cardiovascular diseases","volume":"13","author":"Testai","year":"2021","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.msard.2026.107946_bib0057","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/metabo10090374","article-title":"Metabolomic profiling in neuromyelitis optica spectrum disorder biomarker discovery","volume":"10","author":"Thoman","year":"2020","journal-title":"Metabolites"},{"issue":"24","key":"10.1016\/j.msard.2026.107946_bib0058","doi-asserted-by":"crossref","first-page":"9607","DOI":"10.3390\/ijms21249607","article-title":"The regulation of astrocytic glutamate transporters in health and neurodegenerative diseases","volume":"21","author":"Todd","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.msard.2026.107946_bib0059","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/s41582-024-01014-1","article-title":"NMOSD and MOGAD: an evolving disease spectrum","volume":"20","author":"Uzawa","year":"2024","journal-title":"Nat. Rev. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2026.107946_bib0060","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.msard.2026.107946_bib0061","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1186\/s12967-024-05801-8","article-title":"Integrated omics profiling reveals systemic dysregulation and potential biomarkers in the blood of patients with neuromyelitis optica spectrum disorders","volume":"22","author":"Xie","year":"2024","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.msard.2026.107946_bib0062","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12974-018-1162-0","article-title":"Cerebrospinal fluid mitochondrial DNA in neuromyelitis optica spectrum disorder","volume":"15","author":"Yamashita","year":"2018","journal-title":"J. Neuroinflammation."},{"issue":"20","key":"10.1016\/j.msard.2026.107946_bib0063","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252010918","article-title":"Unveiling the role of gut microbiota and metabolites in autoimmune thyroid diseases: emerging perspectives","volume":"25","author":"Yan","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.msard.2026.107946_bib0064","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186707","article-title":"Thiamine deficiency activates hypoxia inducible factor-1\u03b1 to facilitate pro-apoptotic responses in mouse primary astrocytes","volume":"12","author":"Zera","year":"2017","journal-title":"PLoS. One"},{"issue":"4","key":"10.1016\/j.msard.2026.107946_bib0065","doi-asserted-by":"crossref","DOI":"10.1002\/wsbm.1483","article-title":"Glucose transporter 1 in rheumatoid arthritis and autoimmunity","volume":"12","author":"Zezina","year":"2020","journal-title":"Wiley. Interdiscip. Rev. Syst. Biol. Med."},{"issue":"1","key":"10.1016\/j.msard.2026.107946_bib0066","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41392-025-02493-4","article-title":"mTOR signaling networks: mechanistic insights and translational frontiers in disease therapeutics","volume":"10","author":"Zhang","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.msard.2026.107946_bib0067","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2025.106666","article-title":"Glial-mediated pathogenesis and intervention strategies in neuromyelitis optica spectrum disorder","volume":"103","author":"Zhang","year":"2025","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107946_bib0068","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/3962173","article-title":"Connexin43 and AMPK have essential role in resistance to oxidative stress induced necrosis","volume":"2017","author":"Zhao","year":"2017","journal-title":"BioMed. Res. Int."},{"issue":"1","key":"10.1016\/j.msard.2026.107946_bib0069","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12964-026-02915-y","article-title":"Metabolic reprogramming of Th17\/treg imbalance in autoimmune thyroid diseases","volume":"24","author":"Zhou","year":"2026","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.msard.2026.107946_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2025.103472","article-title":"Altered glucose metabolism in B cells: implications for the pathogenesis and treatment of autoimmune diseases","volume":"156","author":"Zhu","year":"2025","journal-title":"J. Autoimmun."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826009818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826009818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:40:58Z","timestamp":1793954458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826009818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":70,"alternative-id":["S2211034826009818"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107946","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic reprogramming in neuromyelitis optica spectrum disorder: From astrocyte dysfunction to immune-mediated neuroinflammation","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107946","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107946"}}